Novo Nordisk
Pharmaceuticals · NVO
Maker of semaglutide (Wegovy, Ozempic). Its GLP-1 franchise is the cost line employers are rationing, and the market Ilant is built around.
Company profile
- Market cap
- $184.31336692204002B
- Chief executive
- Mike Doustdar
- Headquarters
- Bagsværd, Denmark
- Founded
- 1923
- Staff
- ~77,000